194 related articles for article (PubMed ID: 29902565)
1. Influence of arterial input function (AIF) on quantitative prostate dynamic contrast-enhanced (DCE) MRI and zonal prostate anatomy.
Ziayee F; Müller-Lutz A; Gross J; Quentin M; Ullrich T; Heusch P; Arsov C; Rabenalt R; Albers P; Antoch G; Wittsack HJ; Schimmöller L
Magn Reson Imaging; 2018 Nov; 53():28-33. PubMed ID: 29902565
[TBL] [Abstract][Full Text] [Related]
2. Arterial input function for quantitative dynamic contrast-enhanced MRI to diagnose prostate cancer.
Ziayee F; Mueller-Lutz A; Gross J; Ullrich T; Quentin M; Arsov C; Antoch G; Wittsack HJ; Schimmöller L
Diagn Interv Radiol; 2022 Mar; 28(2):108-114. PubMed ID: 35548894
[TBL] [Abstract][Full Text] [Related]
3. Influence of Different Measurement Methods of Arterial Input Function on Quantitative Dynamic Contrast-Enhanced MRI Parameters in Head and Neck Cancer.
Dong W; Volk A; Djaroum M; Girot C; Balleyguier C; Lebon V; Garcia G; Ammari S; Temam S; Gorphe P; Wei L; Pitre-Champagnat S; Lassau N; Bidault F
J Magn Reson Imaging; 2023 Jul; 58(1):122-132. PubMed ID: 36269053
[TBL] [Abstract][Full Text] [Related]
4. Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method.
Ginsburg SB; Taimen P; Merisaari H; Vainio P; Boström PJ; Aronen HJ; Jambor I; Madabhushi A
J Magn Reson Imaging; 2016 Dec; 44(6):1405-1414. PubMed ID: 27285161
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic analysis of prostate cancer using independent component analysis.
Mehrabian H; Da Rosa M; Haider MA; Martel AL
Magn Reson Imaging; 2015 Dec; 33(10):1236-1245. PubMed ID: 26297961
[TBL] [Abstract][Full Text] [Related]
6. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
Hectors SJ; Besa C; Wagner M; Jajamovich GH; Haines GK; Lewis S; Tewari A; Rastinehad A; Huang W; Taouli B
J Magn Reson Imaging; 2017 Sep; 46(3):837-849. PubMed ID: 28092414
[TBL] [Abstract][Full Text] [Related]
7. Relative sensitivities of DCE-MRI pharmacokinetic parameters to arterial input function (AIF) scaling.
Li X; Cai Y; Moloney B; Chen Y; Huang W; Woods M; Coakley FV; Rooney WD; Garzotto MG; Springer CS
J Magn Reson; 2016 Aug; 269():104-112. PubMed ID: 27288764
[TBL] [Abstract][Full Text] [Related]
8. Impact of contrast agent injection duration on dynamic contrast-enhanced MRI quantification in prostate cancer.
Klawer EME; van Houdt PJ; Pos FJ; Heijmink SWTPJ; van Osch MJP; van der Heide UA
NMR Biomed; 2018 Sep; 31(9):e3946. PubMed ID: 29974981
[TBL] [Abstract][Full Text] [Related]
9. A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation.
Fedorov A; Fluckiger J; Ayers GD; Li X; Gupta SN; Tempany C; Mulkern R; Yankeelov TE; Fennessy FM
Magn Reson Imaging; 2014 May; 32(4):321-9. PubMed ID: 24560287
[TBL] [Abstract][Full Text] [Related]
10. Effects of arterial input function selection on kinetic parameters in brain dynamic contrast-enhanced MRI.
Keil VC; Mädler B; Gieseke J; Fimmers R; Hattingen E; Schild HH; Hadizadeh DR
Magn Reson Imaging; 2017 Jul; 40():83-90. PubMed ID: 28438713
[TBL] [Abstract][Full Text] [Related]
11. Impact of arterial input function selection on the accuracy of dynamic contrast-enhanced MRI quantitative analysis for the diagnosis of clinically significant prostate cancer.
Azahaf M; Haberlay M; Betrouni N; Ernst O; Behal H; Duhamel A; Ouzzane A; Puech P
J Magn Reson Imaging; 2016 Mar; 43(3):737-49. PubMed ID: 26303794
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge, Part II.
Huang W; Chen Y; Fedorov A; Li X; Jajamovich GH; Malyarenko DI; Aryal MP; LaViolette PS; Oborski MJ; O'Sullivan F; Abramson RG; Jafari-Khouzani K; Afzal A; Tudorica A; Moloney B; Gupta SN; Besa C; Kalpathy-Cramer J; Mountz JM; Laymon CM; Muzi M; Kinahan PE; Schmainda K; Cao Y; Chenevert TL; Taouli B; Yankeelov TE; Fennessy F; Li X
Tomography; 2019 Mar; 5(1):99-109. PubMed ID: 30854447
[TBL] [Abstract][Full Text] [Related]
13. Comparison of different population-averaged arterial-input-functions in dynamic contrast-enhanced MRI of the prostate: Effects on pharmacokinetic parameters and their diagnostic performance.
Othman AE; Falkner F; Kessler DE; Martirosian P; Weiss J; Kruck S; Kaufmann S; Grimm R; Kramer U; Nikolaou K; Notohamiprodjo M
Magn Reson Imaging; 2016 May; 34(4):496-501. PubMed ID: 26708031
[TBL] [Abstract][Full Text] [Related]
14. A comparison of arterial spin labeling perfusion MRI and DCE-MRI in human prostate cancer.
Cai W; Li F; Wang J; Du H; Wang X; Zhang J; Fang J; Jiang X
NMR Biomed; 2014 Jul; 27(7):817-25. PubMed ID: 24809332
[TBL] [Abstract][Full Text] [Related]
15. Repeatability of arterial input functions and kinetic parameters in muscle obtained by dynamic contrast enhanced MR imaging of the head and neck.
Koopman T; Martens RM; Lavini C; Yaqub M; Castelijns JA; Boellaard R; Marcus JT
Magn Reson Imaging; 2020 May; 68():1-8. PubMed ID: 31978517
[TBL] [Abstract][Full Text] [Related]
16. Differential diagnosis of prostate cancer and noncancerous tissue in the peripheral zone and central gland using the quantitative parameters of DCE-MRI: A meta-analysis.
Gao P; Shi C; Zhao L; Zhou Q; Luo L
Medicine (Baltimore); 2016 Dec; 95(52):e5715. PubMed ID: 28033274
[TBL] [Abstract][Full Text] [Related]
17. Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation.
Fennessy FM; Fedorov A; Penzkofer T; Kim KW; Hirsch MS; Vangel MG; Masry P; Flood TA; Chang MC; Tempany CM; Mulkern RV; Gupta SN
Magn Reson Imaging; 2015 Sep; 33(7):886-94. PubMed ID: 25683515
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge.
Huang W; Chen Y; Fedorov A; Li X; Jajamovich GH; Malyarenko DI; Aryal MP; LaViolette PS; Oborski MJ; O'Sullivan F; Abramson RG; Jafari-Khouzani K; Afzal A; Tudorica A; Moloney B; Gupta SN; Besa C; Kalpathy-Cramer J; Mountz JM; Laymon CM; Muzi M; Schmainda K; Cao Y; Chenevert TL; Taouli B; Yankeelov TE; Fennessy F; Li X
Tomography; 2016 Mar; 2(1):56-66. PubMed ID: 27200418
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Dynamic Contrast Enhanced MRI with a Split Dose of Gadoterate Meglumine for Detection of Prostate Cancer.
Fan X; Chatterjee A; Pittman JM; Yousuf A; Antic T; Karczmar GS; Oto A
Acad Radiol; 2022 Jun; 29(6):796-803. PubMed ID: 34583866
[TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast-enhanced (DCE) MR imaging: the role of qualitative and quantitative parameters for evaluating prostate tumors stratified by Gleason score and PI-RADS v2.
Afshari Mirak S; Mohammadian Bajgiran A; Sung K; Asvadi NH; Markovic D; Felker ER; Lu D; Sisk A; Reiter RE; Raman SS
Abdom Radiol (NY); 2020 Jul; 45(7):2225-2234. PubMed ID: 31549211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]